1 / 90

Drug Absorption, Distribution, Metabolism, Elimination

Drug Absorption, Distribution, Metabolism, Elimination. Chapter 3. Physical/Chemical Properties of Drugs. Ability to Approach Receptors. Drug Mol’s  Receptors. Bloodstream (cardiovascular system) Bulk flow transfer Fast, long-distance Chem nature of drug not impt Short distances

rebeccacox
Download Presentation

Drug Absorption, Distribution, Metabolism, Elimination

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drug Absorption, Distribution, Metabolism, Elimination Chapter 3

  2. Physical/Chemical Properties of Drugs Ability to Approach Receptors

  3. Drug Mol’s  Receptors • Bloodstream (cardiovascular system) • Bulk flow transfer • Fast, long-distance • Chem nature of drug not impt • Short distances • Diffusion • Chem properties impt

  4. Chem Properties Impt to Diffusion • Aqueous diffusion delivers most drug mol’s • Rate of diffusion dependent on molec size • Diffusion coeff = 1/ qMW • BUT: Most drugs 200-1000 MW, so little difference • Ability to cross barriers • Cell membr’s mostly lipid • Drug hydrophobicity impt

  5. Absorption = Movement Across Cell Barriers • Cell membr’s separate aqueous compartments • Movement through cell involves traversing at least 2 lipid bilayers • Some tight junctions between cells • Ex: CNS, placenta, testes • Some freely permeable • Ex: Liver, spleen • Vascular endothelium differs in permeability

  6. Small Mol’s Cross Cell Membr’s • Diff’n  lipid • Diff’n  aqueous pores traversing lipid bilayer • BUT most pores too small to accomm most drugs • Transmembr carrier prot • Pinocytosis • Not impt for small mol’s

  7. Diffusion • Number mol’s crossing membr per unit area in unit time; depends on • Permeability coefficient (P) • Diffusivity • Diffusion coefficient • Doesn’t differ much between drugs • Solubility in membr • Partition coefficient (solubility oil/solubility water) • Most impt to pharmacokinetics • Used as predictor of drug properties

  8. barbital secobarbital thiopental

  9. pH and Ionization • Many drugs are weak acids/bases • Can be ionized, unionized • Varies w/ pH of environment • Acids release H+ • Strong: All H+ released • Weak: Some H+ released • Ka quantitates strength of acid

  10. Weak acid ionization (HA  H+ + A-) • Ka = [H+][A-]/[HA] • Negative log and rearrangement: • Log [H+] = log Ka + log [A-]/[HA] • pH = pKa + log [A-]/[HA] • Henderson/Hasselbach equation • pKa = pH when drug 50% dissoc’d • Weak base ionization (BH+  H+ + B) • Ka = [H+][B]/[BH+] • Negative log and rearrangement • pH = pKa + log [B]/[BH+]

  11. Rearrangement if known pH, pKa allows deter’n ionized/unionized ratio at any pH environment

  12. pH Differences between Body Compartments • Environmental pH effects ability to release H+ (ionization) • Ionized species have low lipid solubility • Most: uncharged can traverse cell membr’s • So each environment’s pH effects drug dist’n between them • Ion trapping •  Compartment equilibrium

  13. Ex: Stomach  Blood • Assume weak acid drug (HA) w/ pKa=6.0 • Assume [HA]=1.0 • Stomach pH=1.0 • 1.0-6.0=log [A-]/[HA] • 1.0x10-5=[A-] • Little ionized drug • Blood pH=7.0 • 10=[A-] • Much ionized drug • Expect stomach-to-plasma traverse BUT not plasma-to-stomach

  14. Book ex: more basic drug (how do we know?) Plasma  Digestive Tract

  15. Acidic drugs concent’d in high pH compartment • Site of highst dissoc’n H+ (ionization) • Can’t traverse membr to escape • Basic drugs concent’d in low pH environment • Largest D pH between compartments  largest D [drug] • BUT not total impermeability • AND not total equilib • Most impt to gi, renal

  16. Carrier Mediated Transport • Specialized for physiologically impt mol’s • Sugars, neurotransmitters, metals, etc • Transmembr prot • Binds mol(s) • Changes conform’n • Releases to other side of membr • Diff kinetics than simple diffusion • Can become saturated • Subject to competition between ligands

  17. Two types of carriers allow • Facilitated diff’n • Along concent gradient • Active transport • Against gradient • Cell uses chem energy • Carriers impt pharmacologically • Renal tubule • Biliary tract • Blood-brain barrier • GI tract • P-glycoprotein impt drug transporter • Renal tubular cells, bile canaliculi, brain microvessels

  18. Drug Administration

  19. Two Major Routes • Internal • Via gastrointestinal tract (gi) • Oral • Sublingual • Buccal • Parenteral • Via injection • IV • IM • Subcu • Intrathecal

  20. Oral Administration • Convenient; includes most drugs • Little absorption until small intestine • Are most drugs weak acids or bases? • Abs’n from small intestine • Passive transfer dependent on • Ionization • Lipid solubility • Some carrier-mediated transport • Levodopa through carrier for phenylalanine • Fluorouracil through carrier for pyrimidines • Fe, Ca

  21. Rates abs’n after oral admin depend on • Gi motility • Some disorders  gastric stasis • Some drugs affect motility (incr or decr) • Meals • Splanchnic blood flow • Drug particle size/formulation • Capsules/coated tablets • Timed release formulations • Physicochemical factors • Tetracycline binds Ca  milk prevents abs’n • Drug interactions

  22. Bioavailability • Proportion of drug that passes into systemic circ’n after oral admin • Dependent on • Absorption • Local metab by small intestine enzymes • Indiv pts’ physiology impt • Activity intestinal metab enz’s • pH variations • Motility

  23. Differs w/ type dose (oral, IV) • Oral dosing  further metab • Book: First pass effect through liver • = AUCoral/AUCIV x doseIV/doseoral • AUC = Area Under Curve of drug plasma concent vs. time • “Bioequivalence” used to compare generic drugs to patented

  24. Other Types of Drug Admin • Sublingual • Impt when • Rapid response req’d • Drug unstable at gastric pH • Drug rapidly metab’d by liver • Pass straight into systemic circ’n • Don’t enter liver portal system (so no first-pass effect)

  25. Ex: glyceryl trinitrate relieves angina • Metab  NO release • NO act’s soluble guanylate cyclase (sim to ad cyclase) •  incr’d cGMP  act’n prot kinase G •  biochem cascade in smooth muscle •  dephosph’n myosin light chains, sequestering Ca •  vascular smooth muscle relaxation • Also relaxes cardiac muscle •  decr’d bp, so red’d preload, cardiac afterload • So decr’d cardiac O2 consumption • Also redist’n coronary blood flow toward ischemic cardiac areas

  26. Rectal • Abs’n unreliable • Often for local action • Useful in pts vomiting, unable to take by mouth (infants) • Cutaneous • Local effect on skin req’d • Abs’n occurs  systemic effects • Suitable for lipid-soluble mol’s • Ex: estrogen patch

  27. Nasal sprays • Abs’n through mucosa overlaying lymphoid tissue • Impt for drugs inact’d in gi • Ex: peptide hormone analogs, ADH, calcitonin • Inhalation • Large surface area and high blood flow • No gi inact’n • BUT also route of elim’n • Ex: volatile, gaseous anesthetics • Ex: locally acting drugs • Ex: inhaled human insulin being tested

  28. Admin by Injection • Subcutaneous, intramuscular • Faster than oral • Rate abs’n depends on site admin, local blood flow • Red’n or prolonging systemic action poss by altering drug mol or prep’n or giving w/ another agent • Intrathecal • Into subarachnoid space via lumbar puncture • Ex: regional anesthetics • Ex: cancer chemotherapeutics • Ex: antibiotics for NS infections

  29. Intravenous (IV) fastest, most certain • Bolus  high concent R heart, lung, systemic circ’n • Peak concent depends on rate injection • Common ex: antibiotics, anesthetics • Most uncomplicated to understand distribution, pharmacokinetics

  30. Distribution of Drugs in the Body Pharmacokinetics

  31. Experimental Finding • Rates drug abs’n, dist’n, elim’n gen’ly directly proportional to physio concent • First order kinetics • Rate varies w/ first power of concent dC(t)/dt = -kEC(t) where dC(t)/dt = rate change [drug] kE = elimination constant (neg sign due to decr [drug] w/ elim’n) • Note: rate elim’n may be zero order (independent of concentration) • Ex: ethanol

  32. Kinetics Meas’d w/ Single IV Dose • Single bolus over 5-30 sec • Periodic blood samples analyzed for [drug] • Time ~0 – highest concent • Dist’n drug in circulation  equilib • Complete by sev passes through heart (sev min) • Later time – concent decr’s due to • Dist’n  tissues • Dist’n  other body fluids • Metab  other cmpds • Excr’n unchanged drug (renal, biliary, lung)

  33. (Concent (y axis) reflects free drug + drug bound to plasma prot’s) • Conversion to log concent  more linear curve • Non-linear portion – dist’n phase (a phase) • Rapid decr plasma concent • Linear portion – elimination phase (b) • Grad decr plasma concent

  34. Eq’n line for elim’n phase: C(t) = C0e-kEt • Where C(t) = Concent drug @ time (t) C0 = Concent @ time 0 e = nat’l log base kE = rate const for phase (elim’n rate const) t = time • Y int = C0; slope = -kE/2.3 • Can be used to deter rate dist’n when a phase included

  35. With Oral Admin… • Plot differs in a phase • Initial: [plasma] = 0 • Swallowing, dissolution, abs’n take time • Rapid abs’n  rate b phase incr’s • First order: rate incr w/ incr’d [drug] • Peak concent at rate abs’n = rate elim’n

  36. Body Fluid Compartments: Sites of [Drug] • Total body water=50-70% total body wt • Intracell highest • Extracell: • Interstitial = between cells • Plasma = blood + lymph • Transcell = cerebrospinal, intraocular, synovial, etc. • Fat is also compartment • BUT poorly perfused

  37. Dug mol’s exist ionized/unionized, free/bound in each compartment • Dist’n pattern for each drug dependent on • Membrane permeability/transport • Binding w/in compartment • pH partitioning • Fat/water partitioning

  38. Specialized Compartment – Blood Brain Barrier • History: Ehrlich -- dyes injected IV stained most tissues; brain unstained • Contin layer endothelial cells w/ tight junctions • Non-brain – fenestrations • Specific transport for small organics • Safety buffer • Throughout brain, spinal cord • Except floor of hypothal, area postrema

  39. Inaccessible to many drugs unless high lipid solubility • BUT inflamm’n can disrupt integrity • AND some peptides increase bbb permeability • Intrathecal injection sometimes circumvents

  40. Volume of Distribution • Vol fluid req’d to contain drug in body at same concent as that present in plasma • May indicate drug binding to plasma prot or other tissue constituents • Vd = D/C0 • Where Vd = vol dist’n (L) D = dose w/ IV injection (mg) C0 = blood concent @ 0 time (mg/L)

  41. Most impt: free drug in interstitial fluid • Drug values vary greatly • Molecular wt • More impt: binding plasma prot’s

  42. Drug Binding to Plasma Proteins • Reflected in Vd • If high binding, drug “trapped” in plasma • High C0 on graph (Y reflects bound + unbound drug) • For Vd=D/C0, Vd very low (2-10L) • Ex: warfarin (anticoagulant) • If low binding, drug free to disperse  tissues • Low plasma concent (= low C0) • Vd high (40,000 L) • Ex: furosemide (diuretic)

More Related